RBMS1 and hepatocellular carcinoma: More importantly, RBMS1 overexpression inhibited HepG2 and Hep3B cell viability, which was strengthened and prevented by erastin (ferroptosis activator) and ferrostatin-1 (ferroptosis inhibitor), respectively, indicating that RBMS1 hindered HCC cell proliferation by ferroptosis (Figure 2j).